AstraZeneca Settles Toprol Antitrust Action For $20M
AstraZeneca Pharmaceuticals LP on Monday agreed to pay $20 million to settle claims brought in Delaware by a putative class of direct purchasers of Toprol-XL who allege the pharmaceutical giant used...To view the full article, register now.
Already a subscriber? Click here to view full article